The role of alternative splicing in cancer: From oncogenesis to drug resistance

Alternative splicing is a tightly regulated process whereby non-coding sequences of pre-mRNA are removed and protein-coding segments are assembled in diverse combinations, ultimately giving rise to proteins with distinct or even opposing functions. In the past decade, whole genome/transcriptome sequ...

Celý popis

Podrobná bibliografie

Vydáno v:	Drug resistance updates Ročník 53; s. 100728
Hlavní autoři:	Sciarrillo, Rocco, Wojtuszkiewicz, Anna, Assaraf, Yehuda G., Jansen, Gerrit, Kaspers, Gertjan J.L., Giovannetti, Elisa, Cloos, Jacqueline
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Scotland Elsevier Ltd 01.12.2020
Témata:	Alternative splicing Cancer Drug resistance Oncogenesis SF3B1 inhibition Splicing factor mutation Splicing modulation Alternative splicing SF3B1 inhibition Splicing modulation Splicing factor mutation Oncogenesis Drug resistance Cancer
ISSN:	1368-7646, 1532-2084, 1532-2084
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!